Japan Contract Research Organization Market

Aging Population and Liberal Regulations will Propel Clinical Trial Growth

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from preclinical trials to post-marketing surveillance. It provides detailed information on support services such as central laboratory services, bioanalytics, and data management.

Table of Contents

Japan Contract Research Organization MarketExecutive SummaryKey FindingsKey Findings (continued)CRO Market Size by Stage of Clinical DevelopmentMarket Size Estimation MethodologyScope and SegmentationKey Questions this Study will AnswerTotal CRO Market Engineering MeasurementsCEO’s PerspectiveKey Companies to WatchKey Companies to Watch (continued)Market OverviewPharmaceutical Market OverviewPharmaceutical Market Overview (continued)Market PerspectiveClinical Trials Market OverviewClinical Trials Market OverviewClinical Trials Market Overview (continued)Clinical Trials ScenarioProfiles of Clinical TrialsCRO Market Segmentation by Stage of Clinical DevelopmentForecasts and Trends—Total CRO MarketForecast AssumptionsMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionPhase I and Phase II Segments—Revenue ForecastPhase III and Phase IV Segments—Revenue ForecastPreclinical Segment—Revenue ForecastPreclinical Segment Revenue Forecast DiscussionData Management Segment—Revenue ForecastData Management Segment Revenue Forecast Discussion Biostatistics Segment—Revenue ForecastBiostatistics Segment Revenue Forecast DiscussionCentral Laboratory Services Segment—Revenue ForecastCentral Laboratory Services Segment Revenue Forecast Discussion Pharmacovigilance Segment—Revenue ForecastPharmacovigilance Segment Revenue Forecast Discussion Bioanalytics Segment—Revenue ForecastBioanalytics Segment Revenue Forecast Discussion HEOR Segment—Revenue ForecastHEOR Segment Revenue Forecast DiscussionCRO Market—Key TrendsRegulatory EnvironmentClinical Research Regulatory OverviewClinical Research Regulatory Overview (continued) Clinical Research Regulatory ProcessCompetitive EnvironmentCompetitive StructureCompetitive Analysis—Selected Key Market ParticipantsCompetitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)Competitive Analysis—Selected Key Market Participants (continued)The Last WordThe Last Word—DiscussionLegal DisclaimerAppendixList of ExhibitsList of Exhibits (continued)The Frost & Sullivan StoryThe Frost & Sullivan StoryValue PropositionGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.